Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 20 Oct 2022

Case report: Complete resection of invasive thymoma invading the superior vena cava and right atrium under cardiopulmonary bypass support

in Thoracic Oncology

Xiangxin Zhang
Liang Chen
Wenyong Zhou
Zhexin Wang
Chong Wang
Jianxin Shi
Feng Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.1026524

2,393 views
1 citation

Original Research

Published on 20 Oct 2022

Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma

in Thoracic Oncology

Minle Wu
Jie Bao
Youfeng Lei
Shuai Tao
Qiurong Lin
Liang Chen
Yinpeng Jin
Xiaohong Ding
Yufeng Yan
Ping Han

Frontiers in Oncology

doi 10.3389/fonc.2022.935672

3,846 views
5 citations

Review

Published on 19 Oct 2022

The function and clinical implication of circular RNAs in lung cancer

in Thoracic Oncology

Xiulin Jiang
Lincan Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.862602

5,879 views
14 citations

Original Research

Published on 19 Oct 2022

Construction of survival prediction model for elderly esophageal cancer

in Thoracic Oncology

Shuai Qie
Hongyun Shi
Fang Wang
Fangyu Liu
Jinling Gu
Xiaohui Liu
Yanhong Li
Xiaoyue Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.1008326

2,935 views
5 citations

Case Report

Published on 19 Oct 2022

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

in Thoracic Oncology

Xiangyu Xu
Zixia Shi
Dan Fu
Depei Huang
Zheng Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1008932

3,955 views
3 citations

Original Research

Published on 18 Oct 2022

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

in Thoracic Oncology

Cheng-Sen Liu
Ying-Qiu Song
Run-Ze Wang
Zheng Wang
Rong He
Ke Xu
Chen-Yu Wang
Yu Wu
Ye Wang
Xiao-fang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.991378

1,644 views
1 citation

Clinical Trial

Published on 18 Oct 2022

A phase II study of buparlisib in relapsed or refractory thymomas

in Thoracic Oncology

Mohammad I. Abu Zaid
Milan Radovich
Sandra Althouse
Hao Liu
Aaron J. Spittler
Jeffrey Solzak
Sunil Badve
Patrick J. Loehrer

Frontiers in Oncology

doi 10.3389/fonc.2022.891383

3,090 views
13 citations

Case Report

Published on 18 Oct 2022

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

in Thoracic Oncology

Liang Ge-ge
Geng Cuicui
Li Leiqiang
Tian Yongcang
Ma Jiangang
Ou Yiwen
Sun Li-zhe

Frontiers in Oncology

doi 10.3389/fonc.2022.1029679

2,603 views
4 citations

Case Report

Published on 18 Oct 2022

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

in Thoracic Oncology

Woo Kyung Ryu
Hyungkeun Cha
Mi Hwa Park
Jung Soo Kim
Jeong-Seok Choi
Lucia Kim
Kyung-Hee Lee
Hae-Seong Nam

Frontiers in Oncology

doi 10.3389/fonc.2022.900966

3,434 views
3 citations

Original Research

Published on 17 Oct 2022

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

in Thoracic Oncology

Yin Shi
Rui Pei
Shao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.833773

4,800 views
3 citations

Original Research

Published on 17 Oct 2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

in Thoracic Oncology

Stephen V. Liu
Xiaohan Hu
Yeran Li
Bin Zhao
Thomas Burke
Vamsidhar Velcheti

Frontiers in Oncology

doi 10.3389/fonc.2022.999343

7,789 views
24 citations

Original Research

Published on 17 Oct 2022

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

in Thoracic Oncology

Fengling Shao
Huajie Mao
Tengling Luo
Qijun Li
Lei Xu
Yajun Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.894485

5,992 views
19 citations

Original Research

Published on 17 Oct 2022

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

in Thoracic Oncology

Changqing Dong
Wanwan Cheng
Meiling Zhang
Si Li
Lele Zhao
Dongsheng Chen
Yong Qin
Mingzhe Xiao
Shencun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.992596

3,647 views
3 citations

Case Report

Published on 17 Oct 2022

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

in Thoracic Oncology

Filipa Ferreira da Silva
Rita Barata
Inês Rolim
Catarina Carvalheiro
Nuno Gil
Marcos Pantarotto

Frontiers in Oncology

doi 10.3389/fonc.2022.1001627

2,020 views
2 citations

Case Report

Published on 17 Oct 2022

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

in Thoracic Oncology

Dan Han
Kewei Zhao
Qin Yang
Liling Zhang
Shihong Fei

Frontiers in Oncology

doi 10.3389/fonc.2022.1016320

2,194 views
2 citations

Original Research

Published on 14 Oct 2022

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

in Thoracic Oncology

Liang Shi
Qiyi Meng
Li Tong
Hongxia Li
Yujie Dong
Chongyu Su
Zhe Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.956755

4,473 views
6 citations

Original Research

Published on 13 Oct 2022

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

in Thoracic Oncology

Xiuyuan Chen
Hao Xu
Qingyi Qi
Chao Sun
Jian Jin
Heng Zhao
Xun Wang
Wenhan Weng
Shaodong Wang
Xizhao Sui

Frontiers in Oncology

doi 10.3389/fonc.2022.1021084

5,255 views
22 citations

Case Report

Published on 13 Oct 2022

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

in Thoracic Oncology

Shinkichi Takamori
Takashi Seto
Masafumi Yamaguchi
Fumihiko Kinoshita
Takatoshi Fujishita
Kensaku Ito
Ryo Toyozawa
Fumihiro Shoji
Tatsuro Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2022.965741

5,504 views
13 citations

Original Research

Published on 12 Oct 2022

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images

in Thoracic Oncology

Ri-qiang Liao
An-wei Li
Hong-hong Yan
Jun-tao Lin
Si-yang Liu
Jing-wen Wang
Jian-sheng Fang
Hong-bo Liu
Yong-he Hou
Chao Song

Frontiers in Oncology

doi 10.3389/fonc.2022.1002953

5,740 views
17 citations

Original Research

Published on 11 Oct 2022

Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients

in Thoracic Oncology

Pinghua Tu
Xinjun Li
Lingli Cao
Minghua Zhong
Zhibin Xie
Zhanling Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.882018

3,711 views
7 citations

Original Research

Published on 11 Oct 2022

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

in Thoracic Oncology

Yaxin Chen
Lei Xia
Yuxuan Peng
Gang Wang
Liyun Bi
Xue Xiao
Cui Li
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.947808

3,558 views
2 citations

Original Research

Published on 11 Oct 2022

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

in Thoracic Oncology

Arivazhagan Roshini
Chandra Goparaju
Somanath Kundu
Mohan S. Nandhu
Sharon L. Longo
John A. Longo
Joan Chou
Frank A. Middleton
Harvey I. Pass
Mariano S. Viapiano

Frontiers in Oncology

doi 10.3389/fonc.2022.1014749

4,934 views
12 citations

Original Research

Published on 10 Oct 2022

MDFI is a novel biomarker for poor prognosis in LUAD

in Thoracic Oncology

Pengyu Chen
Zhen Quan
Xueyu Song
Zhaojia Gao
Kai Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.1005962

6,374 views
14 citations

Original Research

Published on 07 Oct 2022

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis

in Thoracic Oncology

Sihao Chen
Wanli Yu
Shilong Shao
Jie Xiao
Hansong Bai
Yu Pu
Mengxia Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1027149

4,302 views
10 citations

1,964 articles

articles

Case report: Complete resection of invasive thymoma invading the superior vena cava and right atrium under cardiopulmonary bypass support

Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma

The function and clinical implication of circular RNAs in lung cancer

Construction of survival prediction model for elderly esophageal cancer

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

A phase II study of buparlisib in relapsed or refractory thymomas

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images

Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

MDFI is a novel biomarker for poor prognosis in LUAD

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis